Why would a neurotech VC bet on Anthropic? This article examines how frontier AI, neuroscience, model behavior, and intelligent systems intersect within Kaleida Capital’s NeuroAI thesis and the infrastructure shaping next-generation intelligence.

Neural data is among the richest and most underutilized datasets in AI. This article explores how brain foundation models could reshape NeuroAI, precision neuroscience, brain-computer interfaces, and next-generation intelligent systems.

As neural data access improves and AI systems become more adaptive, NeuroAI is emerging as an investable frontier across brain-computer interfaces, precision neuroscience, and next-generation intelligent systems.

Kaleida Capital backs the pioneers building at the intersection of neuroscience and technology. With deep technical expertise and bold conviction, we’re helping define the next era of human-machine connection.

Manifest Technologies’ journey from Yale computational neuroimaging spinout to Johnson & Johnson acquisition offers a case study in precision neuroscience and NeuroAI. This article explores how machine learning, multimodal neural data, and patient-specific brain mapping can transform CNS drug development, clinical trial design, and therapeutic response prediction.